Kaleido Biosciences
KLDO · OTC
$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
EPS: actual vs estimate
Beat the estimate in 6 of the last 8 quarters, by 5.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q4 FY21 | -$0.5916 | -$0.47 | +20.6% |
| Q3 FY21 | -$0.5525 | -$0.54 | +2.3% |
| Q2 FY21 | -$0.5773 | -$0.56 | +3.0% |
| Q1 FY21 | -$0.6059 | -$0.58 | +4.3% |
| Q4 FY20 | -$0.4063 | -$0.56 | −37.8% |
| Q3 FY20 | -$0.6467 | -$0.65 | −0.5% |
| Q2 FY20 | -$0.6018 | -$0.59 | +2.0% |
| Q1 FY20 | -$0.6528 | -$0.64 | +2.0% |
Earnings calls
- Special Call - Kaleido Biosciences, Inc.
- Morgan Stanley 19th Annual Global Healthcare Conference
- Special Call - Kaleido Biosciences, Inc.
- 39th Annual JPMorgan Virtual Healthcare Conference
- Morgan Stanley 18th Annual Global Healthcare Conference
- Goldman Sachs 41st Annual Global Healthcare Conference
- KLDO - Earnings call Q1 2020
- 2nd Annual Microbiome Medicines Summit
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.